ARTICLE | Company News
Bio-Rad to acquire MorphoSys' AbD Serotec division
December 18, 2012 2:33 AM UTC
Bio-Rad Laboratories Inc. (NYSE:BIO) will acquire the AbD Serotec research and diagnostic antibody division of MorphoSys AG (Xetra:MOR; Pink:MPSYF) for about EUR 53 million ($69.7 million) in cash. Th...